Promptly

About:

Promptly is a Real World Evidence company, collecting, integrating and analyzing data on the outcomes of care.

Website: https://www.promptlyhealth.com/

Twitter/X: PromptlyHealth

Top Investors: PharmStars, Nina Capital, K Fund, Shilling, Pathena

Description:

Promptly is a Health Data Analytics company, collecting, integrating and analyzing data on the outcomes of care. Promptly develops proprietary technology for patient engagement, real-world data collection, and outcomes analytics, discovering digital biomarkers on important symptoms, adverse effects and treatment outcomes, using different sources of data. In partnership with some of the most visionary, forward-looking healthcare organizations, the company leverages this health data to promote better healthcare at lower costs for thousands of patients every day.

Total Funding Amount:

3.84M EUR

Headquarters Location:

Porto, Lisboa, Portugal

Founded Date:

2018-01-01

Contact Email:

hello(AT)promptlyhealth.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-12-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai